Previous 10 | Next 10 |
WIXOM, Mich., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, and Angus Smith, Chief Financial Officer, will present at the Biotech Showcase 2020 as follows: The...
Introduction Through Week 49, the Premium Portfolio has gained +27.75%, beating the S&P 500 benchmark, while actively trading in 14 fewer weeks according to the Momentum Gauge timing signals. These returns represent better than 3 times the return of the Barclay Hedge Fund Index average r...
WIXOM, Mich., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at the 31st Annual Piper Jaffray Healthcare Conference as follows: The presentation wi...
– Company adds experienced medical executive to management team and leading nephrologists to Medical Advisory Board – – Objective to become a leading medical organization in the field of dialysis – WIXOM, Mich., Nov. 20, 2019 (GLOBE NEWSWIRE) -- Rockwell Med...
Rockwell Medical, Inc. (RMTI) Q3 2019 Results Conference Call November 11, 2019 04:30 PM ET Company Participants Judy DiClemente - In-Site Communications, Investor Relations Stuart Paul - President and Chief Executive Officer Angus Smith - Chief Financial Officer John McLaughli...
Rockwell Medical (NASDAQ: RMTI ): Q3 GAAP EPS of -$0.12 beats by $0.04 . More news on: Rockwell Medical, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
– Company reports first full quarter of results for Dialysate Triferic, highlighted by greater than 75% conversion rate from Triferic Evaluation Program – – Signs leading East Coast academic medical center as first Center of Excellence – WIXOM, Mich., No...
Historically, buying small-cap stocks into year-end has been savvy because of the "January Effect", a period of strong excess performance by small-cap stocks that stretches from mid-December through the following May. Over the past decade, the median return of the iShares Russell 2000 ETF (I...
WIXOM, Mich., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus on end-stage renal disease (ESR...
WIXOM, Mich., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (“Rockwell Medical” or the “Company”) (Nasdaq: RMTI) today announced that the Company will release its 2019 third quarter financial results on Monday, November 11, 2019, after the close of the...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...